Please assess the completion status of the following clinical trial:

Trial Title: The Association Between Peri-Operative Hyperglycemia and Major Morbidity and Mortality

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients scheduled for non emergent surgery under either general or regional anesthesia deemed to have moderate to high physiologic stress~* Male and female subjects over the age of 18 with or without a diagnosis of diabetes mellitus~* Patients must be able to provide informed consent~Exclusion Criteria:~* Cognitively impaired~* Non-English or Spanish speaking with no relative present who is fluent in reading and comprehending English or Spanish.~* Female patients of child bearing age who have a positive pregnancy test on admission.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 95 Years
- Healthy Volunteers: f

Study Arms:
- intensive glycemic control (Type: EXPERIMENTAL): In the intensive treatment group, continuous insulin infusion (50 IU of Novolin R \[Novo Nordisk\]) in 50ml of 0.9% saline via infusion pump will be started when the blood glucose level exceeds 110 mg / dL on two consecutive samples and will be adjusted to maintain the blood glucose level between 80 and 110 mg / dL. If the glucose level falls below 80 mg / dL, the insulin infusion will be tapered and discontinued.
- conventional glycemic control (Type: ACTIVE_COMPARATOR): In this group if the subject's blood glucose level should exceed 200 mg/dL the subject will be treated with a continuous insulin infusion to maintain blood glucose levels between 180-200mg/dL

Based on this trial design, predict the completion outcome and termination type (if applicable).